Sigilon Therapeutics Inc

SGTX
22,47
0,00 (0,00%)
03 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
21/8/202314:22EDGAR2Form 15-12G - Securities registration termination [Section..
16/8/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
14/8/202313:25PRNUSLilly Completes Acquisition of Sigilon Therapeutics
11/8/202322:28EDGAR2Form S-8 POS - Securities to be offered to employees in..
11/8/202322:20EDGAR2Form POS AM - Post-Effective amendments for registration..
11/8/202322:16EDGAR2Form 8-K - Current report
11/8/202322:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202322:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202322:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202314:31EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
07/8/202314:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/8/202322:06EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
27/7/202322:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/7/202301:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/7/202322:03EDGAR2Form SC 14D9/A - Solicitation, recommendation statements:..
13/7/202314:18EDGAR2Form SC 14D9 - Solicitation, recommendation statements
29/6/202313:35DJNEli Lilly to Acquire Sigilon Therapeutics
29/6/202313:03EDGAR2Form 8-K - Current report
29/6/202312:45PRNUSLilly to Acquire Sigilon Therapeutics
22/5/202313:30GLOBESigilon Announces Reverse Stock Split of Common Stock
09/5/202313:30GLOBESigilon Therapeutics Reports First Quarter 2023 Financial..
Apertura: Min: Max:
Chiusura: 22,47

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network